The Medical Letter on Drugs and Therapeutics
FROM
ISSUE
1102
April 16, 2001
View Complete Issue         Table of Contents 2019 
A Combination of Fluticasone and Salmeterol For Asthma
Subscribers: Log in to read full article.  Not a subscriber?  Subscribe or purchase article.
A Combination of Fluticasone and Salmeterol For Asthma
April 16, 2001 (Issue: 1102)
Fluticasone propionate, an inhaled corticosteroid, and salmeterol xinafoate, a long-acting beta2-adrenergic agonist, are now available together in a dry-powder inhaler for maintenance treatment of patients with asthma. The new combination is not...more
The Medical Letter is a subscriber-funded nonprofit organization that publishes critical appraisals of new prescription drugs and comparative reviews of drugs for common diseases.

Would you like to read the rest of this article?  Gain access below.

Subscribe
Subscriptions to The Medical Letter on Drugs and Therapeutics include:
  • Print version published and mailed biweekly (26 issues/year)
  • Unlimited online access to current and past issues (1988 - present)
  • Mobile App for iOS, Android, and Kindle Fire
  • FREE online per issue CME/CE
Purchase this article:
Title: A Combination of Fluticasone and Salmeterol For Asthma
Article code: 1102a
 Electronic, downloadable article - $45


Gain access through your organization
Ask your librarian to consider an Institutional Subscription to The Medical Letter.